graft versus host disease, acute
Showing 1 - 5 of 5
GVHD, Acute Trial (CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs), Placebo,
Not yet recruiting
- Graft Versus Host Disease, Acute
- CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs)
- +2 more
- (no location specified)
Dec 6, 2022
Pediatric HSCT Recipients With aGVHD: Prospective Observational
Recruiting
- Graft Versus Host Disease, Acute
- Hematopoietic Stem Cell Transplantation
-
Trieste, ItalyIRCCS Burlo Garofolo
Apr 30, 2022
GVHD, Acute Trial in Suzhou (autologous fecal bacteria)
Recruiting
- Graft Versus Host Disease, Acute
- autologous fecal bacteria
-
Suzhou, Jiangsu, ChinaYe Zhao
Aug 19, 2021
Origin of CEC in Patients After Allo-HSCT
Completed
- Graft Versus Host Disease, Acute
- +2 more
- D-CEC counting
-
Brescia, ItalyASST Spedali Civili di Brescia
Jul 7, 2020
Stem Cell Transplant Complications, GVHD, Acute, Fecal Microbiota Transplantation Trial in Ramat Gan (Fecal Microbiota
Unknown status
- Stem Cell Transplant Complications
- +2 more
- Fecal Microbiota Transplantation
-
Ramat Gan, IsraelChaim Sheba Medical Center
Apr 5, 2018